Octopus Ventures

Octopus Ventures Ltd. is a London-based venture capital firm founded in 2007, specializing in investments across a variety of sectors including health, fintech, deep tech, consumer, and B2B software. The firm supports companies at different stages, from seed funding to pre-IPO, with a strong emphasis on making a positive impact. It typically invests between £0.28 million and £25 million in businesses that demonstrate a minimum EBITDA of £0.5 million. Octopus Ventures prefers to lead investment rounds and often takes a board seat in its portfolio companies, which include notable names such as ManyPets, Cazoo, and Depop. The firm operates primarily in Europe, with a particular focus on the UK, and maintains a network of partners in the U.S. and Asia. In addition to financial backing, Octopus Ventures commits time and resources to help founders scale their businesses effectively.

Kamran Adle

Partner

Tosin Agbabiaka

Investor

Chloe Allan

Investment Manager

Dany Bidar

Principal

Rich Bolton

Principal

Zoe Chambers

Early Stage Investor

Matt Chandler

Investment Manager

Maiuran Chandrakumaran

Investment Associate

Lucy Clarke

Investor

Milly-Louisa Cleal

Portfolio Partner

Chantal Cox

Investment Manager, Health

Paul Davidson

Principal

Emma Davies

Co-CEO

Saranyah Douse

Investment Principal

Jonathan Durnford-Smith

Portfolio Partner

Constanza Díaz

Investment Manager

Fred Ellis

Investment Manager

Malcolm Ferguson

Principal

Tilly Fleming

Associate

Will Gibbs

Investment Manager

Renée Godyn

Early-Stage Fintech Investor

Henry Goodwin

Venture Partner

Luke Hakes

Partner

John Hamm

Venture Partner

Hope Johnson

Investment Manager

Natasha Jones

Early Stage Investor

Edward Keelan

Investment Principal

Simon King

Partner

Tim Lebus

Venture Partner

Flavia Levi

Investor, Deep Tech

Alex Macpherson

Chairman

Jeevs Mahil

Portfolio People Partner

Bryony Marshall

Principal

Jessica McCreadie

Principal

Jess McCreadie

Principal

Karan Mehta

Early Stage Investor

Brandon Mhangami

Investor

Ben Newsome

Portfolio Partner

Amy Nommeots-Nomm

Investor

Shamik Parekh

Early-stage Investor

Ian Perry

Venture Partner

Rosie Phillips

Investor, Consumer

Jebran Raashed

Investment Manager

Uthishtan Ranjan

Partner

Uthish Ranjan

Partner

Zoë Reich

Fund Manager

Patricia Ruiz

Investment Manager

Adam Said

Principal

Pooja Sikka

Partner

Joe Stringer

Partner

Hugo Villanueva

Investor, Biotech

Tanya Yankova

Investor, Healthtech

Owen Metters

Investment Manager

Owen Metters Ph.D

Investment Manager, Deep Tech

Constanza Díaz

Investment Manager

Past deals in Personal Health

Manual

Venture Round in 2024
Manual is a men's health and well-being startup based in London, UK, founded in 2018. The company specializes in providing a suite of diagnostic tools and blood tests that facilitate data-driven health solutions tailored for men. Manual aims to destigmatize discussions surrounding men's health by offering easy access to advice, free medical support, and treatment options. Its platform addresses various health concerns, including weight management, anxiety, insomnia, fatigue, and general wellness. By empowering men with the necessary information and resources, Manual encourages proactive decision-making regarding their health and well-being.

Pelago

Series C in 2024
Pelago, formerly known as Quit Genius, is a leading virtual clinic focused on substance use management, particularly for tobacco, alcohol, and opioids. The company aims to transform support for substance use by offering education, management skills, and opportunities for positive change to individuals struggling with addiction. Pelago provides employers with a means to offer on-demand, personalized support for employees seeking healthier lifestyles. Its platform utilizes cognitive behavioral therapy (CBT) to address the psychological aspects of addiction, helping users identify triggers and access support through animated videos, interactive exercises, and audio sessions. This approach allows individuals to work at their own pace with the assistance of a personalized coach. Pelago's services seamlessly integrate with health plans, pharmacy benefit managers, and wellness platforms, and the company has successfully supported over 750,000 members in managing their substance use and improving their overall well-being.

Harbiz

Venture Round in 2024
Harbiz is a developer of an all-in-one productivity software tailored for wellness and fitness professionals. The platform aims to digitize and streamline business operations within the fitness sector by providing a comprehensive suite of tools. These tools include training resources, customer management features, automated notifications, customized nutrition plans, and payment automation. Additionally, Harbiz focuses on facilitating the connection between wellness professionals and their clients, while offering capabilities for tracking progress and personalizing user experiences. Through its platform, Harbiz seeks to enhance the efficiency and professionalism of businesses in the fitness industry.

Alba Health

Pre Seed Round in 2023
Alba Health specializes in digital gut health support for children, utilizing artificial intelligence and gut microbiome testing. The company offers a microbiome testing service that provides comprehensive insights into a child's gut health through an easy-to-use stool test kit. This kit is analyzed in a certified laboratory, and the detailed results are returned to parents, who can then collaborate with dieticians to develop personalized action plans to enhance their child's health. Additionally, Alba Health anonymizes the test results, potentially contributing to broader discoveries that could improve children's overall health and well-being.

Pear Bio

Series A in 2023
Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Skin + Me

Series B in 2023
Skin + Me Ltd is a digital health company based in London, United Kingdom, that specializes in online dermatology consultation services. Founded in January 2018, the company offers personalized skincare solutions aimed at treating various skin concerns, including acne, signs of aging, uneven texture, dark spots, and enlarged pores. Through its direct-to-consumer model, Skin + Me provides patients with access to online consultations with dermatologists and pharmacists, along with prescription-based therapy creams. This approach ensures that clients receive tailored guidance, treatment, and ongoing support for their skin health needs.

Elo Health

Series A in 2023
Elo Health is a provider of personalized nutrition services that focus on promoting health and wellness through tailored supplements. The company utilizes biomarkers, artificial intelligence, and expert guidance to create nutrition solutions that cater to individual needs. By analyzing blood tests, activity data, and offering one-on-one support from dietitians, Elo Health identifies and addresses nutrient gaps specific to each customer. Its Smart Nutrition products are designed based on scientifically proven ingredients, enabling users to adopt and maintain healthier lifestyles effectively.

Visible

Pre Seed Round in 2022
Wearable technology to measure and manage complex chronic illlness

Vira Health

Series A in 2022
Vira Health is a digital health company dedicated to enhancing long-term health outcomes for women by focusing on female-specific conditions. The company develops digital therapeutics that provide evidence-based interventions for managing menopause symptoms, including insomnia, anxiety, depression, hot flushes, weight gain, and incontinence. Vira's approach also aims to delay the onset of chronic health issues such as osteoporosis, cardiovascular disease, and dementia through personalized care and tailored treatment plans. By improving the collection and use of female health data, Vira Health seeks to address the unique challenges women face throughout their lives, particularly during menopause.

Big Health

Series C in 2022
Big Health is a digital therapeutics company based in London, United Kingdom, specializing in sleep improvement solutions. It offers a digital healthcare portal that provides fully automated and personalized behavioral programs aimed at addressing mental health issues, particularly sleep disorders. The flagship application, Sleepio, utilizes Cognitive Behavioral Therapy techniques to tailor interventions to individual users' needs, helping them effectively manage and overcome their sleep-related challenges. By consulting with medical professionals, Big Health ensures that its programs are both evidence-based and user-friendly, promoting better sleep and overall mental well-being.

Tuune

Seed Round in 2021
Tuune is a femtech startup focused on transforming women's health through personalized hormonal analysis and tailored birth control solutions. The company has developed a platform that creates contraceptive plans based on individual biological profiles, medical histories, mental health considerations, genetic information, and hormone levels. By offering this customized approach, Tuune aims to help users minimize the side effects often associated with oral contraceptives, thereby enhancing overall well-being and health outcomes for women.

Pelago

Series B in 2021
Pelago, formerly known as Quit Genius, is a leading virtual clinic focused on substance use management, particularly for tobacco, alcohol, and opioids. The company aims to transform support for substance use by offering education, management skills, and opportunities for positive change to individuals struggling with addiction. Pelago provides employers with a means to offer on-demand, personalized support for employees seeking healthier lifestyles. Its platform utilizes cognitive behavioral therapy (CBT) to address the psychological aspects of addiction, helping users identify triggers and access support through animated videos, interactive exercises, and audio sessions. This approach allows individuals to work at their own pace with the assistance of a personalized coach. Pelago's services seamlessly integrate with health plans, pharmacy benefit managers, and wellness platforms, and the company has successfully supported over 750,000 members in managing their substance use and improving their overall well-being.

Medisafe

Series C in 2021
Medisafe is a digital patient engagement platform focused on improving medication adherence and management. By utilizing a data-driven approach, the platform personalizes patient engagement, helping users navigate the complexities of their medication schedules. Medisafe addresses common challenges associated with non-adherence by providing features that send alerts to users and their caretakers, ensuring timely medication intake. With nearly 5 million registered users and over 2 billion recorded medication doses, the app has demonstrated its effectiveness in improving adherence by up to 20%, as evidenced by various studies. The platform engages both patients and healthcare partners, offering insights into behavior patterns that enhance the patient experience. Medisafe has received multiple accolades for its innovation in healthcare, including recognition from Gartner and Fast Company, and boasts high user satisfaction ratings, making it a leading solution in medication management.

Big Health

Series B in 2020
Big Health is a digital therapeutics company based in London, United Kingdom, specializing in sleep improvement solutions. It offers a digital healthcare portal that provides fully automated and personalized behavioral programs aimed at addressing mental health issues, particularly sleep disorders. The flagship application, Sleepio, utilizes Cognitive Behavioral Therapy techniques to tailor interventions to individual users' needs, helping them effectively manage and overcome their sleep-related challenges. By consulting with medical professionals, Big Health ensures that its programs are both evidence-based and user-friendly, promoting better sleep and overall mental well-being.

Pelago

Series A in 2020
Pelago, formerly known as Quit Genius, is a leading virtual clinic focused on substance use management, particularly for tobacco, alcohol, and opioids. The company aims to transform support for substance use by offering education, management skills, and opportunities for positive change to individuals struggling with addiction. Pelago provides employers with a means to offer on-demand, personalized support for employees seeking healthier lifestyles. Its platform utilizes cognitive behavioral therapy (CBT) to address the psychological aspects of addiction, helping users identify triggers and access support through animated videos, interactive exercises, and audio sessions. This approach allows individuals to work at their own pace with the assistance of a personalized coach. Pelago's services seamlessly integrate with health plans, pharmacy benefit managers, and wellness platforms, and the company has successfully supported over 750,000 members in managing their substance use and improving their overall well-being.

Katalyst

Series A in 2019
Katalyst is a company focused on making fitness accessible to all individuals, aiming to help them achieve their full potential. It has developed an electro muscle stimulation system that promotes health and fitness through innovative technology. This system provides a comprehensive full-body workout that activates a significant portion of muscle fibers without the need for external weights or causing joint strain. By using this approach, Katalyst enables users to enhance their overall strength and endurance, improve body composition, and achieve better muscle tone and definition while addressing muscular imbalances.

Katalyst

Seed Round in 2017
Katalyst is a company focused on making fitness accessible to all individuals, aiming to help them achieve their full potential. It has developed an electro muscle stimulation system that promotes health and fitness through innovative technology. This system provides a comprehensive full-body workout that activates a significant portion of muscle fibers without the need for external weights or causing joint strain. By using this approach, Katalyst enables users to enhance their overall strength and endurance, improve body composition, and achieve better muscle tone and definition while addressing muscular imbalances.

Medisafe

Series B in 2017
Medisafe is a digital patient engagement platform focused on improving medication adherence and management. By utilizing a data-driven approach, the platform personalizes patient engagement, helping users navigate the complexities of their medication schedules. Medisafe addresses common challenges associated with non-adherence by providing features that send alerts to users and their caretakers, ensuring timely medication intake. With nearly 5 million registered users and over 2 billion recorded medication doses, the app has demonstrated its effectiveness in improving adherence by up to 20%, as evidenced by various studies. The platform engages both patients and healthcare partners, offering insights into behavior patterns that enhance the patient experience. Medisafe has received multiple accolades for its innovation in healthcare, including recognition from Gartner and Fast Company, and boasts high user satisfaction ratings, making it a leading solution in medication management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.